BFNH BioForce Nanosciences Holdings (PK)

BioForce Nanosciences Holdings, Inc. (OTCBB: BFNH), a leader in systems integration at the micro and nano scales to create products for the life sciences, is pleased to announce that researchers at the Massachusetts Institute of Technology ("MIT") have published their latest work with the Nano eNabler(TM) molecular printer in the nanotechnology journal "Small." The manuscript, titled "Cell-Compatible, Multi-Component Protein Arrays with Subcellular Feature Resolution" was released online on October 10, 2008, and is in the October print issue of the journal.

In their paper, Ying Mei, Ph.D. and Daniel Anderson, Ph.D., post-doctoral researchers in the laboratory of Professor Robert Langer, demonstrate the fabrication with the Nano eNabler of micro scale arrays containing large numbers of single-component and multiple-component protein spots of varying densities to study the adhesion and spreading of mouse muscle cells. The researchers discovered that through use of the Nano eNabler they were able to create protein arrays which allowed them to align the mouse cells that had been deposited onto the arrays. This ability to control the alignment of cells has utility in the growth of organized cellular structures, an important prelude to future work in the areas of stem cell differentiation and tissue engineering.

BioForce's Product Manager, Michael Lynch, said, "We are proud to have our technology validated by such a high-profile lab. This publication demonstrates the effectiveness of the Nano eNabler for constructing complex cellular microenvironments. The market's need for the Nano eNabler is demonstrated by the researchers' comments in the paper about the Nano eNabler's unique ability to effectively create arrays containing the desired one to ten microns feature sizes. Without the Nano eNabler's capabilities, this project, and the future work to be performed by MIT and other Nano eNabler users in areas such as stem cell differentiation and tissue engineering, would not be possible."

On October 23, 2008, Dr. Ying Mei presented the findings published in their paper through a free BioForce-hosted online seminar. The title of his webinar presentation was "Cell-Compatible, Multi-Component Protein Arrays with Subcellular Feature Resolution" and interested viewers may download a video of the webinar from the BioForce Resources Library.

For further information about this release please contact Greg Brown, Chief Financial Officer of BioForce at 515-233-8333 ext. 118, or Rich Kaiser, Investor Relations at 800-631-8127.

About BioForce Nanosciences Holdings, Inc.

BioForce Nanosciences creates products and solutions for the life sciences by integrating biological and mechanical systems at the micro and nano scales. BioForce's flagship product, the Nano eNabler(TM) molecular printer, gives the Company and its customers a platform for development and discovery by printing tiny domains of biological materials on surfaces with nanometer spatial precision. BioForce technology is being used in areas such as biosensor functionalization; pattering and cell adhesion; and the printing of proteins to guide neural cell growth. For more information, visit www.bioforcenano.com or call 515-233-8333.

This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.

Contacts: Company Contact Gregory D. Brown Chief Financial Officer 515-233-8333 ext# 118 Email Contact Investor Relations Yes International Rich Kaiser 800-631-8127